Cross-institution positioning
Oct 7, 2026Accumulation leaning. 2 accumulating, 1 reducing, 1 exited across 4 comparable institutions.
Source: Schedule 13 researchSCOTTS MIRACLE-GRO CO
Latest stored close $49.86 as of Oct 9, 2026 View live quote ↗
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
Accumulation leaning. 2 accumulating, 1 reducing, 1 exited across 4 comparable institutions.
Source: Schedule 13 research2 increased/new, 0 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsOver the last 90 days, SEC-coded non-derivative P/S activity includes 0 purchases by 0 reporting owners and 4 sales by 3 reporting owners. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/56 non-amendment material events in the last 90 days; Latest classified evidence: Termination of material agreement. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataRevenue +1.1% YoY; Net income -24.7% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsRecent close is 18% through its reported 52-week range; -7.3% over one year.
Source: Stored historical price seriesFiled Oct 7, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
See each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Comparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Compare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | Scheiwer Mark J | MExercise or conversion of derivative · derivative · amendment | Dividend Equivalent Rights | 500 | $0.00 | Direct | Oct 9, 2026 |
| Oct 2, 2026 | Scheiwer Mark J | MExercise or conversion of derivative · amendment | Common Shares | 500 | $0.00 | Direct | Oct 9, 2026 |
| Oct 2, 2026 | Scheiwer Mark J | FTax/price withholding or payment | Common Shares | 1.6K | $49.02 | Direct | Oct 5, 2026 |
| Oct 1, 2026 | Johnson Stephen L | AGrant, award, or other acquisition | Common Shares | 144 | — | Direct | Oct 5, 2026 |
| Oct 1, 2026 | Sandoval Brian E | AGrant, award, or other acquisition | Common Shares | 575 | — | Direct | Oct 5, 2026 |
| Sep 30, 2026 | Scheiwer Mark J | JOther transaction | Common Shares | 3 | $45.88 | Direct | Oct 5, 2026 |
| Sep 28, 2026 | Scheiwer Mark J | AGrant, award, or other acquisition · derivative | Phantom Stock | 15 | $50.27 | Direct | Sep 30, 2026 |
| Sep 5, 2026 | Baxter Nathan Eric | FTax/price withholding or payment | Common Shares | 12.0K | $57.53 | Direct | Sep 9, 2026 |
| Sep 4, 2026 | Sandoval Brian E | AGrant, award, or other acquisition · derivative | Dividend Equivalent Rights | 179 | — | Direct | Sep 9, 2026 |
| Sep 4, 2026 | Scheiwer Mark J | AGrant, award, or other acquisition · derivative | Dividend Equivalent Rights | 47 | — | Direct | Sep 9, 2026 |
| Sep 4, 2026 | Scheiwer Mark J | AGrant, award, or other acquisition · derivative | Phantom Stock | 16 | $59.71 | Direct | Sep 9, 2026 |
| Sep 4, 2026 | Miaritis Nick | AGrant, award, or other acquisition · derivative | Dividend Equivalent Rights | 72 | — | Direct | Sep 9, 2026 |
| Sep 4, 2026 | Hanft Adam | AGrant, award, or other acquisition · derivative | Dividend Equivalent Rights | 118 | — | Direct | Sep 9, 2026 |
| Sep 4, 2026 | Kingdon Mark D | AGrant, award, or other acquisition · derivative | Dividend Equivalent Rights | 118 | — | Direct | Sep 9, 2026 |
| Sep 4, 2026 | Johnson Stephen L | AGrant, award, or other acquisition · derivative | Dividend Equivalent Rights | 155 | — | Direct | Sep 9, 2026 |
| Sep 4, 2026 | Shumlin Peter E | AGrant, award, or other acquisition · derivative | Dividend Equivalent Rights | 170 | — | Direct | Sep 9, 2026 |
| Sep 4, 2026 | HAGEDORN KATHERINE LITTLEFIELD | AGrant, award, or other acquisition · derivative | Dividend Equivalent Rights | 37 | — | Direct | Sep 9, 2026 |
| Sep 4, 2026 | Evans David C | AGrant, award, or other acquisition · derivative | Dividend Equivalent Rights | 118 | — | Direct | Sep 9, 2026 |
| Sep 4, 2026 | Miller Austin Scott | AGrant, award, or other acquisition · derivative | Dividend Equivalent Rights | 53 | — | Direct | Sep 9, 2026 |
| Sep 4, 2026 | Candelino Roberto | AGrant, award, or other acquisition · derivative | Dividend Equivalent Rights | 77 | — | Direct | Sep 9, 2026 |
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Sep 25, 2026 | 8-K/AAmendment | 5.02 | Director or executive change | — | Filing |
| Sep 15, 2026 | 8-K | 1.02, 8.01, 9.01 | Termination of material agreement; Other event; Financial statements / exhibits | — | Filing |
| Sep 11, 2026 | 8-K | 5.02 | Director or executive change | — | Filing |
| Sep 3, 2026 | 8-K | 5.02 | Director or executive change | — | Filing |
| Aug 27, 2026 | 8-K | 1.01, 9.01 | Material definitive agreement; Financial statements / exhibits | — | Filing |
| Jul 29, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Jul 1, 2026 | 8-K | 5.02, 9.01 | Director or executive change; Financial statements / exhibits | — | Filing |
| Apr 29, 2026 | 8-K | 2.02, 7.01, 9.01 | Results of operations / financial condition; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Apr 9, 2026 | 8-K | 8.01, 9.01 | Other event; Financial statements / exhibits | — | Filing |
| Feb 20, 2026 | 8-K | 2.02, 9.01 | Results of operations / financial condition; Financial statements / exhibits | — | Filing |
| Feb 13, 2026 | S-8 | — | Employee-plan securities registration | Equity | Filing |
| Jan 29, 2026 | 8-K | 5.02, 5.07, 9.01 | Director or executive change; Shareholder vote results; Financial statements / exhibits | — | Filing |
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
| Period | Revenue | YoY |
|---|---|---|
| Ended Jun 27, 2026 | $1.2B | +1.1% |
| Ended Mar 28, 2026 | $1.5B | +5.0% |
| Ended Dec 27, 2025 | $354.4M | -3.3% |
| Ended Jun 28, 2025 | $1.2B | -3.6% |
| Period | Revenue | YoY |
|---|---|---|
| Ended Sep 30, 2025 | $3.4B | -3.9% |
| Ended Sep 30, 2024 | $3.6B | +0.0% |
| Ended Sep 30, 2023 | $3.6B | -9.5% |
| Ended Sep 30, 2022 | $3.9B | -20.3% |
Dated price context from the historical market series already collected for this security.
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Fidelity / FMR CIK0000315066 | Sep 30, 2026 observed Oct 7, 2026 filed · 7d Schedule 13G amendment | Reported accumulation | 5.9K +1.8K | 10.10% +3.10 pts | $50.11 | $50.52 | $49.86 |
| Fidelity / FMR CIK0000315066 | Jun 30, 2026 observed Aug 6, 2026 filed · 37d Initial Schedule 13G | Initial Schedule 13G | 4.1K | 7.00% | $68.11 | $62.11 | $49.86 |
| Vanguard Group CIK0000102909 | Mar 13, 2026 observed Mar 27, 2026 filed · 14d Schedule 13G amendment | Reported reduction | 11 -4.6M | 12.00% +3.78 pts | $60.96 | $60.65 | $49.86 |
Compare SMG with other securities showing similar institutional activity or recent accumulation across several tracked institutions.